Staar Surgical CO Form 4 insider transactions

Warren Foust, COO of STAAR Surgical, reports the disposition of shares to cover tax obligations following the vesting of restricted stock units.

Magda Michna, Chief Clinical, Regulatory, of STAAR Surgical, reports disposition of 1,670 shares to cover tax obligations after RSU vesting.

Director Aimee Weisner of STAAR Surgical Co. recently purchased 1,750 shares of common stock at a price of $38.11 per share.

Thomas Frinzi, CEO of STAAR Surgical, received stock options and restricted stock units on March 12, 2024, according to a Form 4 filing with the SEC.

Warren Foust, Chief Operating Officer of STAAR Surgical, reports the acquisition of restricted stock units and stock options.

Nathaniel Sisitsky, General Counsel of STAAR Surgical Co., reports the acquisition of restricted stock units and stock options.

Magda Michna, Chief Clinical, Regulatory, and Medical Affairs Officer at STAAR Surgical, reports the acquisition of restricted stock units and stock options.

Patrick F. Williams, CFO of STAAR Surgical, reports the acquisition of stock options and restricted stock units, according to a Form 4 filing with the SEC.

Arthur Butcher joins Staar Surgical's Board of Directors and receives equity compensation in the form of restricted shares and stock options.

Wei Jiang was appointed to STAAR Surgical's Board of Directors and granted stock and restricted stock units as part of standard director compensation.

Patrick Williams, CFO of STAAR Surgical, reports the vesting of performance stock units and continued holdings of restricted stock units.